期刊
CA-A CANCER JOURNAL FOR CLINICIANS
卷 71, 期 6, 页码 488-504出版社
WILEY
DOI: 10.3322/caac.21697
关键词
antibiotic resistance; antibiotics; bacterial infections; cancer
类别
Antibiotic resistance poses a significant threat to the success of cancer therapy, necessitating measures to control its emergence. Establishing a specialized monitoring system and finding better ways to predict, prevent, and treat antibiotic-resistant infections will have a positive impact on the care of cancer patients.
Infection is the second leading cause of death in patients with cancer. Loss of efficacy in antibiotics due to antibiotic resistance in bacteria is an urgent threat against the continuing success of cancer therapy. In this review, the authors focus on recent updates on the impact of antibiotic resistance in the cancer setting, particularly on the ESKAPE pathogens (Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp.). This review highlights the health and financial impact of antibiotic resistance in patients with cancer. Furthermore, the authors recommend measures to control the emergence of antibiotic resistance, highlighting the risk factors associated with cancer care. A lack of data in the etiology of infections, specifically in oncology patients in United States, is identified as a concern, and the authors advocate for a centralized and specialized surveillance system for patients with cancer to predict and prevent the emergence of antibiotic resistance. Finding better ways to predict, prevent, and treat antibiotic-resistant infections will have a major positive impact on the care of those with cancer.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据